Prolactin induces enhanced interferon gamma release in peripheral whole blood after stimulation with either PHA or LPS

Immunobiology

Volumn 206, Issue 4, 2002, Pages 424-431

  Breidthardt, Tobias ^a   Frohn, Christoph ^a   Luhm, Jürgen ^a   Kirchner, Holger ^a   Brand, Jörg Matthias ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ENDOTOXIN; GAMMA INTERFERON; LIPOPOLYSACCHARIDE; PHYTOHEMAGGLUTININ; PLANT LECTIN; PROLACTIN; RECOMBINANT PROTEIN;

ARTICLE; BLOOD ANALYSIS; BLOOD CELL; BLOOD DONOR; CELL CULTURE; CELL STIMULATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN EXPERIMENT; IMMUNOCOMPETENT CELL; IMMUNOLOGY; INFECTION; INFLAMMATION; NEUROENDOCRINOLOGY; NORMAL HUMAN; PRIORITY JOURNAL; TISSUE INJURY; BIOSYNTHESIS; BLOOD; DRUG EFFECT; HYPERPROLACTINEMIA; IMMUNOMODULATION; IN VITRO STUDY;

BLOOD CELLS; HUMANS; HYPERPROLACTINEMIA; INTERFERON TYPE II; LIPOPOLYSACCHARIDES; NEUROIMMUNOMODULATION; PHYTOHEMAGGLUTININS; PROLACTIN; RECOMBINANT PROTEINS;

EID: 0036775858     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1078/0171-2985-00191     Document Type: Article

References (37)

1. NAGY, E., and I. BERCZI 1989. Pituitary dependence of bone marrow function. Br. J. Haematol. 71: 457-462.
2. NAGY, E., I. BERCZI, and H. G. FRIESEN. 1983. Regulation of immunity in rats by lactogenic and growth hormones. Acta Endocrinol. 102: 351-357.
3. BERCZI, I., E. NAGY, S. L. ASA, and K. KOVACS. 1983. Pituitary hormones and contact sensitivity in rats. Allergy 38: 325-330.
4. NAGY, E., and I. BERCZI. 1991. Hypophysectomized rats depend on residual prolactin for survival. Endocrinol. 128: 2276-2784.
5. SINHA, Y. N. 1995. Structural variants of prolactin: occurrence and physiological significance. Endocr. Revolution. 16(3): 353-369.
6. MATERA, L. 1996. Endocrine, paracrine and autocrine actions of prolactin on immune cells. Life sci. 59: 599-614.
7. PELLEGRINI, I., G. GUNZ, C. RONIN, E. FENOUILLET, J. P. PYRAT, P. DELORI, and P. JAQUET. 1988. Polymorphism of prolactin secreted by human prolactinoma cells: immunological, receptor binding and biological properties of the glycosylated and nonglycosylated forms. Endocrinology 122(6): 2667-2674.
8. PRICE, A. E., K. B. LOGVINENKO, E. A. HIGGINS, E. S. COLE, and S. M. RICHARDS. 1995. Studies on the microheterogeneity and in vitro activity of glycosylated and nonglycosylated recombinant human prolactin separated using a novel purification process. Endocrinology 136(11): 4827-33.
9. HASHIM, I. A., R. ASTON, J. BUTLER, A. M. McGREGOR, C. R. SMITH, and M. NORMAN. 1990. The proportion of glycosylated prolactin in serum is decreased in hyperprolactinemic states. J. Clin. Endocrinol. Metab. 71(1): 111-115.
10. MARKOFF, E., D. W. LEE, and D. R. HOLLINGSWORTH. 1988. Glycosylated and nonglycosylated prolactin in serum during pregnancy. J. Clin. Endocrinol. Metab. 67(3): 519-553.
11. MONTGOMERY D. W., G. K. SHEN, E. D. ULRICH, L. L. STEINER, P. R. PARRISH, and C. F. ZUKOSKI. 1992. Human thymocytes express a prolactin-like messenger ribonucleic acid and synthesize bioactive prolactin-like proteins. Endocrinology 131(6): 3019-3026.
12. RUSSELL, D. H., R. KIBLER, L. MATRISIAN, D. F. LARSON, B. POULOS, and B. E. MAGUN. 1985. Prolactin receptors on human T and B lymphocytes: Antagonism of prolactin binding by cyclosporin. J. Immunol. 134: 3027-3031.
13. MATERA, L., G. MUCCIOLI, A. CESANO, G. BELLUSSI, and E. GENAZZANI. 1988. Prolactin receptors on large granular lymphocytes: Dual regulation by cyclosporin A. A. Brain Behav. Immun. 2: 1-10.
14. KIRCHNER, H., CH. KLEINICKE, and W. DIGEL. 1982. A Whole-Blood Technique for Testing Production of Human Interferon by Leukocytes. J. Immunol. Meth. 48: 213-219.
15. CESARIO, T. C., S. YOUSEFI, G. CARANDANG, H. SADATI, J. LE, and N. VAZIRI. 1994. Enhanced Yields of Gamma Interferon in Prolactin Treated Peripheral Blood Mononuclear Cells. Proc. Soc. Exp. Biol. Med. 205: 89-95.
16. MATERA, L., M. CONTARINI, G. BELLONE, B. FORNO, and A. BIGLINO. 1999. Up-modulation of Interferon-gamma mediates the enhancement of spontaneous cytotoxicity in prolactin-activated natural killer cells. Immunol. 98: 386-392.
17. MATERA, L., and M. MORI. 2000. Cooperation of Pituitary Hormone and Prolactin with Interleukin-2 and Interleukin-12 on Production of Interferon-gamma by Natural Killer and T Cells. Ann. NY Acad. Sci. 917: 505-513.
18. TRINCHIERI, G. 1994. Interleukin 12: a cytokine produced by antigen presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 84(12): 4008-4027.
19. FRUCHT, D. M., T. FUKAO, C. BOGDAN, H. SCHINDLER, J. J. O'Shea, and S. KOYASU. 2001. IFN-gamma production by antigen-presenting cells: mechanisms emerge. Trends in Immunol. 22(10): 556-559.
20. SULIMAN, A. M., F. al-saber, F. HAYES, T. FIAD, S. CUNNINGHAM, and T. J. MCKENNA. 2000. Hyperprolactinaemia: analysis of presentation, diagnosis and treatment in the endocrine service of a general hospital. Ir. Med. J. 93(3): 74-76.
21. GERBER, H. 1990. Abnormal hormone values: do drugs play a role? Abnormal prolactin, TSH and thyroid hormone values. (article in German) Schweiz. Med. Wochenschr. 120(23): 847-854.
22. BENKER, G., C. JASPERS, G. HAUSLER, and D. REINWEIN. 1990. Control of Prolactin secretion. Klin. Wochenschr. 68(23): 1157-1167.
23. CEPICKY, P., S. SULKOVA, A. STROUFOVA, Z. ROTH, and I. BURDOVA. 1992. The correlation of serum prolactin level and psychic stress in women undergoing a chronic hemodialysis programme. Exp. Clin. Endocrinol. 99(2): 71-72.
24. BROCKMANN, C., W. RAASCH, and C. BASTIAN. 2000. Endocrine stress parameters during TIVA with remifentanil or sufentanil (article in German). Anaesthesiol Intensimed. Notfallmed. Schmerzther. 35(11): 685-691.
25. JULLIEN, Y., A. ROCHETTE, G. DESCH, B. DESCOMPS, and J. DU CAILAR. 1985. Bromocriptine inhibition of hyperprolactinemia during surgery. Acta Obstet. Gynecol. Scand. 64(5): 403-405.
26. ARNETZ, B. B., G. LAHNBORG, P. ENEROTH, and S. THUNELL. 1984. Age-related differences in the serum prolactin response during standardized surgery. Life Sci. 35(26): 2675-2680.
27. BRAND, J. M., P. SCHMUCKER, T. BREIDTHARDT, and H. KIRCHNER. 2001. Upregulation of IFN-gamma and soluble Interleukin-2 Receptor Release and Altered Serum Cortisol and Prolactin Concentration during General Anaesthesia. J. Interferon Cytokine Res. 21: 793-796.
28. YU-LEE, L. Y. 1997. Molecular Actions of Prolactin in the Immune System. Proc. Soc. Exp. Biol. Med. 215: 35-52.
29. NORTHOFF, H., A. BERG, and C. WEINSTOCK. 1998. Similarities and differences of the immune response to exercise and trauma: the IFN-gamma concept. Can. J. Physiol. Pharmacol. 76: 487-504.
30. HELD, T. K., X. WEIHUA, L. YUAN, D. V. KALVAKOLANU, and A. S. CROSS. 1999. Gamma interferon augments macrophage activation by lipopolysaccaride by two distinct mechanisms, at the signal transduction level and via an autocrine mechanism involving tumor necrosis factor alpha and interleukin-1. Infect. Immun. 67: 206-212.
31. REDMOND, H. P., K. D. CHAVIN, J. S. BROMBERG, and R. J. SHEPARD. 1992. Acute exercise and immune function. Relationship between lymphocyte activity and changes in subset counts. Int. J. Sports. Med. 13(6): 452-461.
32. DENNHARDT, R., H. J. GRAMM, K. MEINHOLD, and K. VOIGT. 1989. Patterns of endocrine secretion during sepsis. Prog. Clin. Biol. Res. 308: 751-756.
33. RAMACHANDRA, R. N., A. H. SEHON, and I. BERCZI. 1992. Neuro-hormonal host defence in endotoxin shock. Brain Behav. Immun. 6(2): 157-169
34. LESHIN, L. S., and P. V. MALVEN. 1984. Bacteremia-induced changes in pituitary hormone release and effect of naloxone. Am. J. Physiol. 247(5Pt1): E585-91.
35. WALKER, S. E., and J. D. JACOBSON. 2000. Roles of prolactin and gonadotropin-releasing hormone in rheumatic diseases. Rheum. Dis. Clin. North Am. 26(4): 713-736.
36. WALKER, S. E., S. H. ALLEN, and R. W MCMURRA. 1993. Prolactin and autoimmune disease. Trends Endocrinol. Metab. 4: 147.
37. MCMURRAY, R. W. 2001. Bromocriptine in rheumatic and autoimmune diseases. Semin. Arthritis Rheum. 31(1): 21-32